Guillermo González-Estevez

Guillermo González-Estevez

Auto-generated profile, based on publicly available information

Guillermo González-Estevez

Institute of Biomedical Sciences Research, University Center for Health Sciences University of Guadalajara Guadalajara Jalisco Mexico

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GSGabriela Athziri Sánchez-Zuno
Gabriela Athziri Sánchez-Zuno
GGGuillermo González-Estevez
Guillermo González-Estevez
MFMónica Matuz Flores
Mónica Matuz Flores
GMGabriela Macedo
Gabriela Macedo
JHJorge Hernández-Bello
Jorge Hernández-Bello
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
Background: The immunomodulatory effects of vitamin D are known to be beneficial in viral infections; it is also known that its deficiency is associated with a prognosis more critical of Coronavirus Disease 2019. This study aimed to determine baseline vitamin D serum concentrations and the effects of its supplementation in asymptomatic or mildly symptomatic Coronavirus Disease 2019 outpatients. Methods: 42 outpatients were included, 22 of which received a supplement of 10,000 IU of vitamin D3 for 14 days; the remaining 20 outpatients were designated as a control group. Serum levels of transferrin, ferritin, vitamin D, and D-dimer were measured at baseline in both groups. After 14 days, serum levels of total vitamin D were determined in the supplemented group. Results: At baseline, only 19% of infected outpatients had vitamin D levels corresponding to sufficiency. All outpatients with vitamin D insufficiency had at least one symptom associated with the disease, while only 75% of patients with symptoms presented sufficiency. On the seventh and fourteenth day of follow-up, the supplemented group presented fewer symptoms with respect to those non-supplemented. A vitamin D3 dose of 10,000 IU/daily for 14 days was sufficient to raise vitamin D serum concentrations. Conclusions: Immunomodulatory effects of vitamin D appear to be linked to the development of symptoms in positive outpatients. Vitamin D supplementation could have significant benefits in the Western Mexican population.

30 September 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
FTFrancisco Javier Turrubiates-Hernández
Francisco Javier Turrubiates-Hernández
Fabiola Márquez-SandovalFabiola Márquez-Sandoval
Fabiola Márquez-Sandoval
GGGuillermo González-Estevez
Guillermo González-Estevez
ZRZyanya Reyes-Castillo
Zyanya Reyes-Castillo
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
Rheumatoid arthritis (RA) is an autoimmune and inflammatory disease that can cause joint damage. Among the environmental risk factors, diet plays an important role because it can aggravate or attenuate inflammation. Selenium (Se) is considered an essential trace element since it is a structural component of antioxidant enzymes; however, its concentration can be affected by diet, drugs and genetic polymorphisms. Studies have reported that RA patients have a deficient diet in some food groups that is associated with parameters of disease activity. Furthermore, it has been shown that there is an alteration in serum Se levels in this population. Although some clinical trials have been conducted in the past to analyze the effect of Se supplementation in RA, no significant results were obtained. Contrastingly, experimental studies that have evaluated the effect of novel Se nanoparticles in RA-induced models have shown promising results on the restoration of antioxidant enzyme levels. In particular, glutathione peroxidase (GPx) is an important selenoprotein that could have a modulating effect on inflammation in RA. Considering that RA patients present an inflammatory and oxidative state, the aim of this review is to give an overview of the current knowledge about the relevance of Se status in RA.

21 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Sergio Ramírez-PérezSergio Ramírez-Pérez
Sergio Ramírez-Pérez
LHLuis Alexis Hernández-Palma
Luis Alexis Hernández-Palma
EOEdith Oregon-Romero
Edith Oregon-Romero
BABrian Uriel Anaya-Macías
Brian Uriel Anaya-Macías
SGSamuel García-Arellano
Samuel García-Arellano
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
The inflammatory process implicates homeostasis disruption and increased production of inflammatory mediators. Myeloid differentiation primary response 88 (MyD88) is an essential protein recruited after lipopolysaccharide (LPS) and interleukin (IL)-1β stimulation, a process that converges in nuclear factor kappa B (NF-κB) activation, as well as a transcription of several genes of both pro- and anti-inflammatory cytokines. The inhibition of MyD88 has shown efficacy by decrease inflammatory response, and has demonstrated potential application as a therapeutic target in chronic diseases. In this study, we investigate the effect of MyD88 dimerisation inhibitor ST2825 on cytokine production from rhIL-1β and LPS-stimulated peripheral blood mononuclear cells (PBMC) from healthy blood donors (HBD). ST2825 significantly downregulates the production of IFN-γ, IL-6, IL-12, IL-2, IL-15, IL-7, VEGF, IL-1Ra, IL-4, IL-5, IL-13 and IL-9 (p < 0.05) in LPS-stimulated PBMC. Moreover, ST2825 had a relatively low impact on IL-1β signalling pathway inhibition, showing that only a few specific cytokines, such as IFN-γ and IL-1Ra, are inhibited in rhIL-1β-stimulated PBMC (p < 0.01). In conclusion, MyD88 dimerisation inhibitor ST2825 showed high efficacy by inhibiting pro- and anti-inflammatory cytokine production in LPS-stimulated PBMC. Moreover, although rhIL-1β induced a sustained cytokine production (p < 0.05), ST2825 did not show a significant effect in the secretion of neither pro- nor anti-inflammatory cytokines in rhIL-1β-stimulated PBMC.

GMGabriela Macedo
Gabriela Macedo
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
PYPatricia Yokogawa
Patricia Yokogawa
Andrea Carolina Machado-SulbaranAndrea Carolina Machado-Sulbaran
Andrea Carolina Machado-Sulbaran
MLMaría Guadalupe Loza-Rojas
María Guadalupe Loza-Rojas
JHJorge Hernández-Bello
Jorge Hernández-Bello
Developing countries have reported lower molecular diagnostic testing levels due to a lack of resources. Therefore, antibody tests represent an alternative to detect exposure to SARS-CoV-2 and analyze possible risk factors. We aimed to describe and compare the clinical-epidemiological characteristics and the quality of food intake in Mexican individuals with a positive or negative test to antibodies against SARS-CoV-2. We carried out antibody tests and applied a survey to 1799 individuals; 42% were positive, and diabetes was more prevalent in these cases (p < 0.01). No differences were identified in the blood type nor influenza vaccination between groups. Coughing, respiratory distress, muscle pain, joint pain, and anosmia were the most prevalent symptoms among seropositive cases (p < 0.0001). Food intake quality was similar in both groups, except for the most consumed type of fat (p = 0.006). In conclusion, this study supports the association of diabetes as a principal risk factor for SARS-CoV-2 infection in the Mexican population. The results do not support previous associations between blood group or influenza vaccination as protective factors against SARS-CoV-2 infection. However, frequent consumption of polyunsaturated fats is highlighted as a new possible associated factor with COVID-19, which more studies should corroborate as with all novel findings.

3 December 2021 in Revista Alergia México
Verified
Journal Article
Open access
GSGabriela Athziri Sánchez-Zuno
Gabriela Athziri Sánchez-Zuno
EOEdith Oregon-Romero
Edith Oregon-Romero
JHJorge Hernández-Bello
Jorge Hernández-Bello
GGGuillermo González-Estevez
Guillermo González-Estevez
RVRodrigo Vargas-Rosales
Rodrigo Vargas-Rosales
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
Las enfermedades reumáticas autoinmunes son trastornos multisistémicos que afectan principalmente las articulaciones y los músculos; algunos ejemplos de estas afecciones son la artritis reumatoide, el lupus eritematoso sistémico y el síndrome de Sjögren. En general, las enfermedades reumáticas autoinmunes tienen una alta prevalencia en todo el mundo y son altamente incapacitantes para quienes las padecen. Una de las principales limitaciones en la actualidad para el manejo de estas enfermedades es que su factor desencadenante sigue siendo desconocido en la mayoría de los casos y el conocimiento de los factores asociados con su exacerbación es limitado. En esta revisión se explorará la posible relación de las alergias como desencadenante de enfermedades reumáticas autoinmunes. También analizaremos los aspectos básicos y generales de ambas enfermedades y el desarrollo de procesos alérgicos y reacciones de hipersensibilidad a los fármacos utilizados en el tratamiento de enfermedades reumáticas.

GGGuillermo González-Estevez
Guillermo González-Estevez
FTFrancisco Javier Turrubiates-Hernández
Francisco Javier Turrubiates-Hernández
LHLaura Elena Herrera-Jiménez
Laura Elena Herrera-Jiménez
GSGabriela Athziri Sánchez-Zuno
Gabriela Athziri Sánchez-Zuno
MGMELVA Guadalupe HERRERA GODINA
MELVA Guadalupe HERRERA GODINA
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
One of the micronutrients that has attracted the most attention in relation to COVID-19 is vitamin D. Although several factors affect its sufficiency; it has been argued that an optimal diet can ensure the intake of micronutrients with effects on immune response. Therefore, in this work we aimed to evaluate the food intake quality of SARS-CoV-2 positive Mexican patients and some of the common factors related to vitamin D deficiency. We conducted a cross-sectional study in 40 SARS-CoV-2 positive patients. Serum samples and clinical parameters were collected. Micronutrient intake and food intake quality were assessed with a 24-h dietary recall and the Mini-ECCA v.2, respectively. Thirty-eight percent of the sample had a healthy food intake. The median 25(OH)D concentration was 22.7 ng/mL. A considerable insufficient intake of micronutrients with immunomodulatory effects such as vitamin D (p < 0.0001), vitamin E (p < 0.0001), and zinc (p < 0.0001) was shown. Patients with 25(OH)D sufficiency, defined as a concentration >30 ng/mL, had better food intake quality (p = 0.02) and an intense physical activity (p = 0.03). In conclusion, a better level of food intake quality and intense physical activity are associated with 25(OH)D sufficiency in SARS-CoV-2 positive Mexican patients.